@article{f6c55b9c6b72404b878a60ea35d3baa0,
title = "A life-course approach to cardiovascular disease prevention",
author = "{de Lemos}, {James A.} and Navar, {Ann M}",
note = "Funding Information: J.A.d.L. has received personal fees for participating in steering or data safety monitoring committees from Amgen, Regeneron, Verve Therapeutics, Novo Nordisc, Eli Lilly and Astra Zeneca. A.M.N. has received funding for research to her institution from BMS, Esperion, Amgen, and Janssen, and personal fees from Amarin, Amgen, Astra Zeneca, BI, Bayer, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, New Amsterdam, and Pfizer.",
year = "2022",
doi = "10.1038/s41591-022-01870-8",
language = "English (US)",
journal = "Nature medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
}